Area of investment and support

Area of investment and support: Population and systems medicine

MRC supports research which provides mechanistic insights into the pathophysiology of major human organs and systems, and the impact of extrinsic factors on the development and trajectory of ill health across the life course.

Duration:
Ongoing
Partners involved:
Medical Research Council (MRC)

The scope and what we're doing

Through our funding mechanisms, including applicant-led and strategic investment we support a portfolio of research in the following science areas:

  • mechanisms underlying ill health of human organs and systems (except the nervous and immune systems)
  • maternal ill health and the early origins of disease
  • nutrition (related to ill health and disease) and obesity
  • trauma, acute medicine and surgery
  • inflammation related to disease processes and the resolution of the inflammatory response
  • lifestyle, socio-economic and behavioural impacts on disease
  • health inequalities
  • ageing in the context of ill health
  • multiple long-term conditions
  • rare diseases
  • population and disease-related cohorts relevant to the above science areas

Our remit includes research of global health relevance, including the needs of people in low and middle-income countries, which should include equitable collaborations with researchers based in those countries.

Strategic activities and partnerships

When concerted action in needed, MRC invests through major investment including, institutes, units and MRC Centres of Research Excellence.

These incorporate strong leadership, mission-focused research, training or capacity-building, and the application of innovative technology and methodology to tackle major research challenges.

These investments include strategic partnerships with host universities, and some involve joint support with other funders.

Find out more about institutes, units and centres and facilities and resources that we support.

We also work with a large number of funding partners, research charities and industries to support and promote further research in population and systems medicine.

We also work with a large number of funding partners, research charities and industries to support and promote further research in population and systems medicine.

UKRI and internal partnerships

To increase our data-driven and systems-based approach, we:

  • connect our portfolio interests with Health Data Research UK, a national MRC partner institute for health and biomedical informatics research
  • promote interactions with other initiatives in biomedical and health informatics

We took an active role in work that resulted in the cross-council vision for food, nutrition and health research jointly published by the Biotechnology and Biological Sciences Research Council and the Economic and Social Research Council.

National partnerships

Our portfolio includes the following.

UK Rare Disease Research Platform

UK Rare Disease Research Platform is a platform bringing together UK strengths in rare diseases research to improve diagnosis and treatment through better understanding of the disease.

This £14 million investment over five years was supported by MRC and the National Institute for Health and Care Research (NIHR) in July 2023. Funding opportunities in this area support the UK Rare Diseases Framework.

Tackling multimorbidity at scale

‘Tackling multimorbidity at scale’ is a research programme delivered by MRC and the NIHR in partnership with ESRC and in collaboration with the Engineering and Physical Sciences Research Council (EPSRC). MRC has worked in partnership to develop the cross funder multimorbidity research framework (PDF, 230KB) that sets out a vision for how the funding community will drive forward the research agenda to tackle the growing problem of people living with multiple long-term conditions.

UK Longitudinal Linkage Collaboration

UK Longitudinal Linkage Collaboration links routine health data to the data collected as part of UK longitudinal cohort studies. Initiated during the COVID-19 pandemic with support from MRC and the NIHR, it helps improve our understanding of disease and interventions. Ongoing funding from MRC and ESRC has preserved this infrastructure resource to continue to further our understanding of the wider determinants of health.

Our Future Health

Our Future Health is an ambitious public, private and charity partnership supporting the UK’s largest health research programme. MRC encourages high-quality research that draws on this data resources to better understand mechanisms of disease and identify feasible interventions to improve health.

Opportunities, support and resources available

Funding opportunities

You can apply for population and systems medicine research funding through multiple routes. For example, you can apply for:

  • standard grants through the applicant led: discovery research grants mechanism and translational schemes appropriate to the stage and remit of your research
  • fellowships

Who to contact

Science contacts

Programme managers act as the lead for their scientific portfolio across MRC. They interact with the community within their research areas, including on strategic activities, and manage the peer review of associated applications.

Direct your questions to the appropriate programme manager in the first instance or to general enquiries.

Population health

Population sciences and public health research are relevant to all areas of population and systems medicine research. Contact the most appropriate programme manager in the first instance.

Cardiovascular and renal

Dr Helen Bennett-Brown, Programme Manager

Email:

Science areas:

  • cardiovascular disease
  • renal dysfunction and disease
  • trauma and acute medicine (early phase mechanisms)

Respiratory and inflammation

Dr Victoria Lund, Programme Manager

Email: victoria.lund@mrc.ukri.org

Science areas:

  • respiratory diseases (excluding lung cancer and infections)
  • organ specific inflammation (including musculoskeletal)
  • rare diseases
  • gastroenterology
  • dermatology

Metabolic and musculoskeletal

Dr Karen Finney, Programme Manager

Email: karen.finney@mrc.ukri.org

Science areas:

  • hepatic disease
  • metabolic disorders and endocrine disease
  • nutrition (related to ill health and disease)
  • obesity
  • musculoskeletal disease
  • dental disorders

Lifecourse and ageing

Dr Victoria Swann O’Flynn

Email: victoria.swannoflynn@mrc.ukri.org

Science areas include:

  • paediatrics and child ill health (including disorders of foetal development)
  • maternal ill health, including in pregnancy and childbirth
  • disorders of the reproductive system
  • early origins of adult disease
  • multiple long-term conditions
  • ageing in the context of ill health

Other contacts

Dr Graham Campbell, Head of multiple long-term conditions and ageing research

Email: graham.campbell@mrc.ukri.org

Areas include:

  • oversight of population and systems medicine awards
  • strategic lead for multiple long-term conditions and ageing

Jill Jones, Associate Director of Global Health, Population and Systems Medicine

Email: jill.jones@mrc.ukri.org

Overarching responsibility for MRC population and systems medicine research and global health research areas.

General policy and eligibility enquiries

Specific populations and systems medicine enquiries

Email: populationandsystemsmedicine@mrc.ukri.org

Complete the MRC remit query form for remit queries.

For general enquiries about MRC policy and eligibility

Research funding policy and delivery team

Email: rfpd@mrc.ukri.org

UK Research and Innovation Funding Service

Email: support@funding-service.ukri.org

Telephone: 01793 547490

Peer review

Email: peerreview@mrc.ukri.org

Last updated: 14 April 2026

This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services.